Anzeige
Mehr »
Login
Dienstag, 30.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Uran Boom: Die Bullen starten durch - spektakuläre Kursgewinne möglich
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
164 Leser
Artikel bewerten:
(0)

Thrombolysis and Mechanical Thrombectomy for DVT - Two Essential Treatments

LOS ANGELES, July 3, 2014 /PRNewswire/ -- Each year, deep vein thrombosis (DVT) leads to hospitalization for approximately 250,000 Americans, and often leads to serious - and even fatal - complications. Fortunately, at the California Institute for Deep Venous Thrombosis, those suffering from the effects of thrombosis will find the most effective DVT treatment from the renowned Dr. Farshad Malekmehr. The specialist performs a variety of procedures, ranging from standard treatments like anticoagulation and thrombolysis for DVT treatment, to highly effective treatments that can be life-saving for those at high risk for pulmonary embolism and postphlebitic syndrome. Among these, one of the most effective is mechanical thrombectomy for DVT - a revolutionary treatment that Dr. Malekmehr is able to perform with the highest level of expertise, leading to an immediate decrease in pain and swelling among a majority of patients.

While many DVT sufferers find relief through treatment at The California Institute for Deep Venous Thrombosis, many still experience understandable confusion regarding the different DVT treatments. That's why we've broken down the differences between two common procedures - thrombolysis and mechanical thrombectomy - both of which you can learn about below:

Thrombolysis

Normally blood clotting is a good thing - it helps a person to prevent blood loss from an injury such as a cut or graze. When a clot breaks up and ends up traveling through a blood stream, however, it can cause serious issues, disrupting blood flow, potentially depriving oxygen to certain parts of the body and damaging tissue. With thrombolysis, Dr. Malekmehr is able to preserve the valves in the veins, thus decreasing the chance of complications like postphlebitic syndrome or pulmonary embolism. Thrombolysis breaks down blood clots through a method that is commonly called "clot busting," involving various drugs that are derived through streptococcus species or recombinant biotechnology. These agents reduce the size of the clot, allowing blood to flow uninhibited by the offending clot.

Mechanical Thrombectomy

A mechanical thrombectomy is a surgical or percutaneous (accomplished through needle puncture) procedure, in which the blood clot is physically removed. While often effective, a mechanical thrombectomy is often performed on an emergency basis, as it is more invasive than thrombolysis. That's why, for those in need of the procedure, the world-class skill and experience of Dr. Malekmehr is particularly valuable.

As a revered expert in DVT treatment, Dr. Malekmehr will thoroughly investigate each patient's symptoms and health concerns before deciding which procedure will lead to the best possible results. As a board-certified cardiovascular surgeon with specialties in cardiac, vascular and thoracic surgery, Dr. Malekmehr is uniquely qualified to effectively diagnose and treat a variety of symptoms and complications related to DVT.

As Dr. Malekmehr's many loyal patients know, the dedicated surgeon and his team at The California Institute for Deep Venous Thrombosis is the ideal option for those looking to reduce the effects of DVT as much as possible, and when possible, stop blood clots before they start. If you're suffering from DVT, or you're at high risk for the malady due to high risk factors like obesity, immobility or genetic factors, contact the California Institute for Deep Venous Thrombosis for diagnosis and treatment. The Institute can be reached online at www.dvtinfo.com or at 818-908-9752.

PR submitted by Cyberset.com

SOURCE The California Institute for Deep Venous Thrombosis

© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.